DPP-4i also has reno-protective effects independent of glycemic control
Bethesda, MD, United States: National Library of Medicine (US) (2023)
Niu S, Alkhuzam KA, Guan D, et al
Canada Mexico Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Rest of Europe Asia-Pacific China Japan India South Korea Australia Indonesia Singapore Taiwan Thailand Rest of Asia-Pacific RoW Latin America Middle East Africa KEY PLAYERS KYOWA HAKKO, INC
Even when raw materials are present, the system works sluggishly, like an engine running on low oil
Escalation reduces side effects The comparison between the 4mg escalated and 4mg non-escalated cohorts provides critical insight into dosing strategy